Machine Learning Market In Pharma Discussed In A New Research Report

Machine Learning in Pharmaceutical Industry Market is estimated to reach $26.2 billion by 2031, growing at a CAGR of 37.9% from 2022 to 2031. Machine learning algorithms can analyze vast amounts of patient data, including genetic data, medical records, and lifestyle factors, to identify patterns and offer predictions concerning disease outbreaks and individual patient risks. Adoption of machine learning services and solutions is poised for rapid growth, presenting lucrative opportunities for market players. Lack of interoperability can make it difficult to aggregate and analyze data across different departments and business units, which is a key factor expected to hamper the market growth.